Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $189 By Vick Meyer Today, 7:56 AM Wells Fargo maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $186 to $189. JAZZ
Read More 1 minute read Earnings News First Community Q4 EPS $0.36 Up From $0.35 YoY By Benzinga Newsdesk Today, 7:56 AM First Community (NASDAQ:FCCO) reported quarterly earnings of $0.36 per share. This is a 2.86 percent increase over earnings… FCCO
Read More 1 minute read Analyst Ratings News Price Target RBC Capital Maintains Outperform on Proofpoint, Raises Price Target to $160 By Vick Meyer Today, 7:56 AM RBC Capital maintains Proofpoint (NASDAQ:PFPT) with a Outperform and raises the price target from $150 to $160. PFPT
Read More 1 minute read Analyst Ratings News Price Target RBC Capital Maintains Outperform on PPG Industries, Lowers Price Target to $138 By Vick Meyer Today, 7:56 AM RBC Capital maintains PPG Industries (NYSE:PPG) with a Outperform and lowers the price target from $141 to $138. PPG
Read More 5 minute read Earnings General Markets News Jacobs To Exit Most Of XPO The Way He Entered — Unconventionally By FreightWaves Today, 7:56 AM Brad Jacobs didn't build XPO Logistics Inc. (NYSE:XPO) the traditional way. He's not taking it apart the traditional… AMZN
Read More 1 minute read Biotech General Neovasc Highlights Presentations Across Germany Featuring Co.’s Reducer Product By Benzinga Newsdesk Today, 7:56 AM Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve… NVCN
Read More 1 minute read Analyst Ratings News Price Target RBC Capital Maintains Sector Perform on Capital One Financial, Raises Price Target to $105 By Vick Meyer Today, 7:56 AM RBC Capital maintains Capital One Financial (NYSE:COF) with a Sector Perform and raises the price target from $98… COF
Read More 3 minute read Biotech General Neurotrope Awarded $2.7M In Funding By National Institute Of Health To Support Phase 2 Alzheimer’s Study By Benzinga Newsdesk Today, 7:56 AM Analysis to adjust for significant baseline imbalance in Severe Impairment Battery scores between treatment groups shows improvement in… NTRP
Read More 1 minute read Analyst Ratings News Price Target Benchmark Maintains Buy on TAL Education, Raises Price Target to $57 By Vick Meyer Today, 7:56 AM Benchmark maintains TAL Education (NYSE:TAL) with a Buy and raises the price target from $47 to $57. TAL
Read More 2 minute read Dividends Media Retail Sales Costco CEO Talks Special Dividend, Membership Fees In CNBC Interview By Jayson Derrick Today, 7:56 AM Costco Wholesale Corporation (NASDAQ:COST) CEO Craig Jelinek told Jim Cramer in an interview aired Tuesday how the company… COST